Veru cov khoom lag luam ze li peb npaug tom qab kev kho qhov ncauj qhov ncauj COVID-19 ua rau 'cov ntaub ntawv tseem ceeb' txo qis hauv kev tuag

Shares ntawm Veru Inc.
VERU,
+ 182.30%
rocketed 175% mus rau 13-hli siab nyob rau yav tav su kev lag luam hnub Monday, tom qab lub tuam txhab biopharmaceutical tau tshaj tawm cov txiaj ntsig zoo los ntawm nws theem 3 kev sim ntawm nws qhov ncauj kev kho mob COVID-19. Kev lag luam ntim tau nce mus txog 264.2 lab shares, piv nrog cov hnub nruab nrab ntawm tag nrho ntawm 629,400 shares, thiab txaus los ua kom cov khoom lag luam muaj txiaj ntsig zoo tshaj plaws ntawm kev sib pauv loj hauv Asmeskas. Veru tau hais tias cov neeg mob tau pw hauv tsev kho mob me me txog qhov mob hnyav COVID-19, uas muaj kev pheej hmoo siab rau cov neeg laus ua pa nyuaj siab (ARDS) thiab kev tuag, nws qhov ncauj sabizabulin tau ua rau "kuaj kho thiab muaj txiaj ntsig" 55% txo cov neeg tuag. Pawg Neeg Saib Xyuas Kev Nyab Xeeb Kev Nyab Xeeb Cov Ntaub Ntawv "sib koom ua ke" tau pom zoo rau Theem 3 kev sim yuav tsum raug tso tseg ntxov vim tias ua tau zoo, tsis muaj kev txhawj xeeb txog kev nyab xeeb. Veru's Tshuag, uas tau kaw ntawm 16-lub hlis qis rau hnub Friday, tam sim no tau nce 103.4% xyoo rau hnub tim, thaum iShares Biotechnology ETF
IB,
-2.30%
tau poob 14.1% thiab S & P 500
SPX,
-1.69%
tau poob 7.0%.